United States Digital Therapeutics Market [2028]: Top Companies, Size, and Competitive Intelligence - TechSci Research

the United States digital therapeutics market was valued at USD 1.45 billion in 2022.

Introduction

According to the TechSci Research report, "United States Digital Therapeutics Market – Industry Size, Share, Trends, Competition Forecast & Opportunities, 2018-2028F," the United States digital therapeutics market was valued at USD 1.45 billion in 2022. The market is anticipated to exhibit a robust compound annual growth rate (CAGR) of 21.15% throughout the forecast period, 2023-2028. The burgeoning market for digital therapeutics in the United States is driven by several pivotal factors, including the rising prevalence of chronic diseases, a growing focus on preventive healthcare, and the widespread adoption of smartphones and internet technologies. This report delves into the intricate details of these driving forces, explores recent trends, provides a comprehensive competitive analysis, and outlines the future prospects of the market.

 

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "United States Digital Therapeutics Market.”

 

Market Dynamics

Rising Prevalence of Chronic Diseases

The increasing incidence of chronic diseases such as diabetes, cardiovascular diseases, and mental health disorders has created an urgent need for innovative solutions to manage these conditions effectively. According to the Centers for Disease Control and Prevention (CDC), chronic diseases account for approximately 75% of the USD 3.5 trillion annual healthcare spending in the United States. The prevalence of these conditions is largely preventable, and the introduction of digital therapeutics offers a promising approach to mitigate their impact.

Focus on Preventive Healthcare

There is a growing recognition of the importance of preventive healthcare among individuals and healthcare providers. Early intervention and proactive measures are essential to maintaining health and well-being. Government initiatives, such as the Patient Protection and Affordable Care Act (PPACA) of 2010, have aimed at making preventive care more affordable and accessible. These initiatives have spurred the adoption of digital therapeutics, which provide preventive treatment options and incentivize early intervention.

Surge in Smartphone and Internet Usage

The proliferation of smartphones and internet usage has provided a fertile ground for digital therapeutics to thrive. These technologies leverage the power of mobile devices and connectivity to deliver personalized and accessible healthcare solutions to individuals anytime and anywhere. This convenience and accessibility have revolutionized healthcare delivery, empowering individuals to take control of their health and engage in self-care.

Recent Trends in Digital Therapeutics

Technological Advancements

The digital therapeutics market is witnessing rapid technological advancements that are enhancing the efficacy and reach of these interventions. Artificial intelligence (AI) and machine learning algorithms are being employed to analyze vast amounts of patient data and provide personalized treatment recommendations. These technologies enable the identification of patterns and early signs of chronic conditions, facilitating timely and effective interventions.

Integration with Virtual Reality and Augmented Reality

Virtual reality (VR) and augmented reality (AR) technologies are being integrated into digital therapeutics to create immersive and interactive experiences that enhance the effectiveness of interventions. These technologies offer novel ways to engage patients in therapeutic activities, improve adherence to treatment plans, and provide real-time feedback.

Data Integration with Healthcare Technologies

The integration of digital therapeutics with other healthcare technologies, such as electronic health records (EHR) and remote monitoring devices, is enabling seamless data exchange and real-time monitoring of patients' progress. This integration facilitates more comprehensive and personalized care, allowing healthcare providers to make informed decisions and adjustments to treatment plans based on real-time data and insights.

AI-Driven Personalized Therapies

Artificial intelligence is revolutionizing digital therapeutics by providing data-driven insights and personalized treatment plans. AI algorithms analyze patient data to identify trends, predict health outcomes, and suggest tailored interventions. This level of personalization enhances the effectiveness of treatments and improves patient outcomes.

Market Opportunities

Large Undiagnosed and Untreated Population

Despite the availability of highly effective and low-cost treatment options for chronic disorders, a significant portion of the population remains undiagnosed and untreated. According to the World Health Organization (WHO), many people affected by chronic diseases do not receive the required treatment and care. In 2019, over one billion people with hypertension (82% of all people with hypertension worldwide) lived in low and middle-income countries. The prevalence of undiagnosed, untreated, and undertreated conditions such as hypertension and chronic obstructive pulmonary disease (COPD) presents a substantial opportunity for the digital therapeutics market.

Drivers of Market Growth

Government Legislation and Initiatives

Government legislation and initiatives play a crucial role in driving the adoption of digital therapeutics. Programs incentivizing preventive treatment options, such as the PPACA, have become popular, encouraging the use of digital therapeutics for early intervention and proactive health management.

Impact of COVID-19

The COVID-19 pandemic has significantly accelerated the adoption of digital therapeutics. Social distancing and self-isolation measures have led to increased anxiety and stress among the population. According to Mental Health America, there was nearly a 19% increase in clinical anxiety in the first week of February 2020 and around a 12% increase in the first two weeks of March. Digital therapeutics have proven effective in managing these conditions and providing evidence-based solutions during the pandemic.

Competitive Analysis

The United States digital therapeutics market is characterized by the presence of several major companies that are at the forefront of innovation in this field. These companies are leveraging technological advancements to develop cutting-edge digital therapeutic solutions. Key players in the market include:

• Noom Inc.
• Omada Health Inc.
• WellDoc, Inc.
• Pear Therapeutics Inc.
• Proteus Digital Health Inc.
• Resmed, Inc. (Propeller Health)
• Akili Interactive Labs
• Better Therapeutics
• 2Morrow Inc.
• Ginger
• Fitbit Inc. (Twin Health Inc.)
• Livongo Health, Inc.

Recent Developments

1. Roche: In November 2022, Roche announced the FDA's approval of the VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, marking the first immunohistochemistry (IHC) companion diagnostic test authorized to aid in the identification of epithelial ovarian cancer (EOC) patients.
2. Agilent Technologies Inc.: In January 2023, Agilent Technologies Inc. announced its acquisition of Avida Biomed, an emerging life sciences company specializing in advanced target enrichment workflows. These workflows offered unique capabilities tailored for clinical researchers utilizing next-generation sequencing (NGS) methods to investigate cancer. The acquisition strengthened Agilent’s esteemed SureSelect portfolio and supported its strategic goal of expanding its footprint in the fast-evolving clinical research and diagnostics domains.
3. QIAGEN and OncXerna: In August 2021, QIAGEN and OncXerna teamed up to advance the Xerna TME panel as an in-vitro diagnostic (IVD) for Navicixizumab, an ovarian cancer treatment. This diagnostic aimed to determine if patients with angiogenesis-driven ovarian cancer could benefit from Navicixizumab. The collaboration enhanced QIAGEN’s NGS companion diagnostics in immuno-oncology, strengthening the company's competitive edge.

Segmentation of the Digital Therapeutics Market

The United States digital therapeutics market is segmented based on product, sales channel, application, regional distribution, and company. This segmentation provides a detailed understanding of the market dynamics and helps identify growth opportunities in different segments.

By Product

Digital therapeutics products include mobile applications, wearable devices, telemedicine platforms, and software programs that offer therapeutic interventions for various medical and psychological conditions. These products are designed to prevent, manage, and treat a wide range of health issues.

By Sales Channel

Digital therapeutics are distributed through various sales channels, including direct-to-consumer (DTC), business-to-business (B2B), and business-to-government (B2G) channels. The choice of sales channel depends on the target audience and the specific needs of the healthcare providers and patients.

By Application

The digital therapeutics market caters to diverse applications, including preventive care, chronic disease management, mental health, and wellness. Preventive applications dominate the market, driven by the increasing emphasis on proactive health management and the need to reduce healthcare costs.

By Regional Distribution

The market is segmented into different regions within the United States, with the West region playing a pivotal role in driving growth. The West region's vibrant ecosystem of leading technology corporations, startups, and esteemed educational institutions fosters continuous innovation and advancements in digital therapeutics.

 

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "United States Digital Therapeutics Market.”

 

 

Key Market Trends

Growing Adoption of Digital Therapeutics

The adoption of digital therapeutics is on the rise, driven by the increasing prevalence of chronic diseases and the need for effective management solutions. Patients and healthcare providers are increasingly recognizing the benefits of digital therapeutics in improving health outcomes and reducing healthcare costs.

Advancements in Telemedicine

Telemedicine platforms are becoming an integral part of digital therapeutics, providing remote access to healthcare services and enabling real-time monitoring of patients' health. The integration of telemedicine with digital therapeutics enhances the delivery of personalized and accessible healthcare solutions.

Emphasis on Patient Engagement

Digital therapeutics are designed to enhance patient engagement and adherence to treatment plans. The use of gamification, interactive features, and real-time feedback mechanisms motivates patients to actively participate in their health management, leading to better health outcomes.

Expansion of Preventive Applications

Preventive applications are gaining prominence in the digital therapeutics market. These applications focus on monitoring health conditions, providing early warnings, and offering personalized recommendations to prevent the onset of chronic diseases. The emphasis on preventive care is expected to drive the growth of the market.

 

Download Free Sample Report

Customers can also request 10% free customization on this report.

 

 

Recently Published Report –

United States Women’s Health Market

United States Sex Reassignment Hormone Therapy Market

United States Frontotemporal Dementia Market

 

Blog: A Guide to Raw Milk Testing: Ensuring Safety from Farm to Table

 

Contact

US -

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +13322586602

Email: [email protected]

Web: https://www.techsciresearch.com/